Search research articles
Contact Us
Filters
Showing results (31-40 of 167) with videos related to
Page
of 17
Sort By:
Chest
|
May 15, 2007
Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service
Samuel G Johnson, Daniel M Witt, Todd R Eddy, et al.
Thrombosis Research
|
March 26, 2013
Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty
Nathan P Clark, Stephanie E Cho, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis
|
February 23, 2020
The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring
Aubrey E Jones, Jordan B King, Kibum Kim, et al.
Pharmacotherapy
|
March 26, 2010
Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy
Nathan P Clark, Thomas Delate, Steven J Cleary, et al.
Thrombosis Research
|
March 14, 2025
Who are we bridging? Description of warfarin patients receiving injectable bridging therapy
Sara R Vazquez, Connor Jensen, Aaron S Wilson, et al.
Thrombosis Journal
|
October 16, 2021
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Pall T Onundarson, Ragnar Palsson, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis
|
March 14, 2008
A descriptive evaluation of warfarin use in patients receiving hospice or palliative care services
Robin R Hill, Kerri D Martinez, Thomas Delate, et al.
Thrombosis Research
|
August 25, 2009
Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy
Nathan P Clark, Thomas Delate, Steven J Cleary, et al.
Pharmacotherapy
|
June 8, 2013
Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy
Adriane N Irwin, Kathleen H McCool, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis
|
July 19, 2019
Description of anti-Xa monitoring practices during low molecular weight heparin use
Albert Lin, Sara R Vazquez, Aubrey E Jones, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 167) with videos related to
Sort By:
Page
of 17
Chest
|
May 15, 2007
Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service
Samuel G Johnson, Daniel M Witt, Todd R Eddy, et al.
Thrombosis Research
|
March 26, 2013
Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty
Nathan P Clark, Stephanie E Cho, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis
|
February 23, 2020
The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring
Aubrey E Jones, Jordan B King, Kibum Kim, et al.
Pharmacotherapy
|
March 26, 2010
Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy
Nathan P Clark, Thomas Delate, Steven J Cleary, et al.
Thrombosis Research
|
March 14, 2025
Who are we bridging? Description of warfarin patients receiving injectable bridging therapy
Sara R Vazquez, Connor Jensen, Aaron S Wilson, et al.
Thrombosis Journal
|
October 16, 2021
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Pall T Onundarson, Ragnar Palsson, Daniel M Witt, et al.
Journal of Thrombosis and Thrombolysis
|
March 14, 2008
A descriptive evaluation of warfarin use in patients receiving hospice or palliative care services
Robin R Hill, Kerri D Martinez, Thomas Delate, et al.
Thrombosis Research
|
August 25, 2009
Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy
Nathan P Clark, Thomas Delate, Steven J Cleary, et al.
Pharmacotherapy
|
June 8, 2013
Assessment of warfarin dosing requirements after bariatric surgery in patients requiring long-term warfarin therapy
Adriane N Irwin, Kathleen H McCool, Thomas Delate, et al.
Journal of Thrombosis and Thrombolysis
|
July 19, 2019
Description of anti-Xa monitoring practices during low molecular weight heparin use
Albert Lin, Sara R Vazquez, Aubrey E Jones, et al.
Page
of 17